[1]
2026. QSAR, human hepatocellular carcinoma anticancer screening, docking studies and in silico prediction of some N-(substituted)-9-alkyl-1- substituted-9H-β-carboline-3-carboxamide derivatives. International Journal of Multidisciplinary and Current Research. 14, 2 (Mar. 2026), 180–192. DOI:https://doi.org/10.14741/ijmcr/v.14.2.11.